Many scientists have criticized the FDA for approving Aduhelm, a costly Alzheimer’s drug that may not do much to slow the disease. But a patient taking the drug says it has given him hope.
Many scientists have criticized the FDA for approving Aduhelm, a costly Alzheimer’s drug that may not do much to slow the disease. But a patient taking the drug says it has given him hope.